Omalizumab-A Review.
Article Details
- CitationCopy to clipboard
Godse K, Mehta A, Patil S, Gautam M, Nadkarni N
Omalizumab-A Review.
Indian J Dermatol. 2015 Jul-Aug;60(4):381-4. doi: 10.4103/0019-5154.160490.
- PubMed ID
- 26288408 [ View in PubMed]
- Abstract
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.